About Novoic
Novoic focuses on the early detection of Alzheimer's disease using artificial intelligence to analyze speech patterns. Their technology can identify subtle cognitive impairments in a quick, 10-minute process that can be performed anywhere, making it accessible to a wide range of users. The software is designed to be user-friendly and can be used on any smart device, which helps ensure high usability rates. Novoic primarily serves medical institutions, with over 50 centers currently utilizing their technology, and aims to reach underserved communities where access to Alzheimer's detection is limited. Their AI algorithms have been validated through clinical trials and are built on diverse datasets to enhance their predictive capabilities. The goal of Novoic is to provide reliable and accessible early detection of Alzheimer's disease, improving healthcare outcomes for individuals at risk.